Literature DB >> 2324244

In-vitro fertilization: influence of women's age on pregnancy rates.

C Piette1, J de Mouzon, A Bachelot, A Spira.   

Abstract

An analysis of the influence of women's age on the results of in-vitro fertilization was performed, using 5590 attempts collected during the year 1986. Increasing age was found to be related to decreased success rates from 19.8% per attempt below the age of 25 years, to 9% per attempt at 40 years or more. A cut-off point was found between the ages of 36 and 37 years, using a mathematical model. The decrease was related to a reduction in oocyte production (4.3 +/- 2.8 at 25 years or less and 3.3 +/- 2.1 at 40 years or more, P less than 0.001), and to a reduced implantation rate, whatever the number of transferred embryos. These findings were not due to spouse's age, rank of attempt, infertility diagnosis or oocyte stimulation regimen, since the effect of age remained significant when a logistical model including these confounders was applied. Finally, a woman's age must be considered as a prognostic factor when IVF is proposed to infertile couples.

Entities:  

Mesh:

Year:  1990        PMID: 2324244     DOI: 10.1093/oxfordjournals.humrep.a137041

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  27 in total

1.  Age and fertility: results of assisted reproductive technology in women over 40 years.

Authors:  C Wood; I Calderon; A Crombie
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Cumulus cells apoptosis as an indicator to predict the quality of oocytes and the outcome of IVF-ET.

Authors:  K S Lee; B S Joo; Y J Na; M S Yoon; O H Choi; W W Kim
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

3.  The influence of advanced age on the outcome of assisted reproduction.

Authors:  J E Dew; R A Don; G J Hughes; T C Johnson; S J Steigrad
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

4.  Associations between IVF outcomes and essential trace elements measured in follicular fluid and urine: a pilot study.

Authors:  Mary E Ingle; Michael S Bloom; Patrick J Parsons; Amy J Steuerwald; Pamela Kruger; Victor Y Fujimoto
Journal:  J Assist Reprod Genet       Date:  2016-12-09       Impact factor: 3.412

5.  Uterine vascularization and pregnancy outcome in patients undergoing intracytoplasmatic sperm injection: the role of nitric oxide.

Authors:  C Battaglia; N Persico; F Mancini; P De Iaco; Paolo Busacchi; F Facchinetti; D de Aloysio
Journal:  J Assist Reprod Genet       Date:  2006-06-14       Impact factor: 3.412

6.  In vitro fertilization and embryo transfer in Israel: 1990 results from a national survey.

Authors:  D S Seidman; Y Lotan
Journal:  J Assist Reprod Genet       Date:  1994-01       Impact factor: 3.412

7.  Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response.

Authors:  A Ebrahim; G Rienhardt; S Morris; T F Kruger; C J Lombard; J P Van der Merwe
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

8.  Toxic trace metals and human oocytes during in vitro fertilization (IVF).

Authors:  Michael S Bloom; Patrick J Parsons; Amy J Steuerwald; Enrique F Schisterman; Richard W Browne; Keewan Kim; Gregory A Coccaro; Giulia C Conti; Natasha Narayan; Victor Y Fujimoto
Journal:  Reprod Toxicol       Date:  2010-01-22       Impact factor: 3.143

9.  Blastomere cytoplasmic granularity is unrelated to developmental potential of day 3 human embryos.

Authors:  Laura Rienzi; Filippo Ubaldi; Maria Giulia Minasi; Marcello Iacobelli; Francisco Martinez; Jan Tesarik; Ermanno Greco
Journal:  J Assist Reprod Genet       Date:  2003-08       Impact factor: 3.412

10.  Basal follicle stimulating hormone (FSH) predicts response to controlled ovarian hyperstimulation (COH)-intrauterine insemination (IUI) therapy.

Authors:  T H Burwinkel; J E Buster; J L Scoggan; S A Carson
Journal:  J Assist Reprod Genet       Date:  1994-01       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.